Clinical, Radiological, Lung Function, and Quality of Life Characterization of Patients With Severe/Critical Infection by SARS-COV-2 (COVID-19) Virus, After 6 and 12 Months of Hospital Discharge

Fundacion Clinica Valle del Lili1 site in 1 country112 target enrollmentNovember 15, 2020

ConditionsCovid19

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Covid19
Sponsor: Fundacion Clinica Valle del Lili
Enrollment: 112
Locations: 1
Primary Endpoint: Radiological alterations
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A descriptive study to characterize clinical, radiological, lung function and quality of life alterations in patients who survived a severe or critical disease caused by SARS-COV-2 virus, who were treated in the intensive care unit of a high complexity institution in Cali, Colombia.

Registry

clinicaltrials.gov

Start Date

November 15, 2020

End Date

July 1, 2022

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Fundacion Clinica Valle del Lili

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•≥ 19 years old who had a positive test for SARS-COV-2 virus
•Patients with a severe and critical disease by SARS-COV-2, who were treated at the ICU of Fundación Valle del Lili, and survived
•Patients with chest radiography or CT scan at admission to the hospital